# Cardiac Perfusion and Metabolism With [11C] Acetate PET/CT is Associated With Hematopoietic System Activation in Acute Decompensated Heart Failure: An Imaging Sub-study

> **NCT03924102** · PHASE1 · WITHDRAWN · sponsor: **University of Alabama at Birmingham**

## Conditions studied

- Acute Decompensated Heart Failure

## Interventions

- **DRUG:** Cardiac Perfusion and Metabolism with [11C] Acetate PET/CT

## Key facts

- **NCT ID:** NCT03924102
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-12-31
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was not able to enroll any eligible subjects.
- **Last updated:** 2023-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03924102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03924102, "Cardiac Perfusion and Metabolism With [11C] Acetate PET/CT is Associated With Hematopoietic System Activation in Acute Decompensated Heart Failure: An Imaging Sub-study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03924102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*